CoChat

Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension

Open access
Mouraret, Nathalie, Marcos, Elisabeth, Abid, Shariq, Gary-Bobo, Guillaume, Saker, Mirna, Houssaini, Amal, Dubois-Rande, Jean-Luc, Boyer, Laurent, Boczkowski, Jorge, Derumeaux, Geneviève, Amsellem, Valérie, Adnot, Serge · 2013 · Circulation
Cited by 123

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background—: Induction of cellular senescence through activation of the p53 tumor suppressor protein is a new option for treating proliferative disorders. Nutlins prevent the ubiquitin ligase MDM2 (murine double minute 2), a negative p53 regulator, from interacting with p53. We hypothesized that cell senescence induced by Nutlin-3a exerted therapeutic effects in pulmonary hypertension (PH) by limiting the proliferation of pulmonary artery smooth muscle cells (PA-SMCs). Methods and Results—: Nutlin-3a treatment of cultured human PA-SMCs resulted in cell growth arrest with the induction of senescence but not apoptosis; increased phosphorylated p53 protein levels; and expression of p53 target genes including p21, Bax, BTG2, and MDM2. Daily intraperitoneal Nutlin-3a treatment for 3 weeks dose-dependently reduced PH, right ventricular hypertrophy, and distal pulmonary artery muscularization in mice exposed to chronic hypoxia or SU5416/hypoxia. Nutlin-3a treatment also partially reversed PH in chronically hypoxic or transgenic mice overexpressing the serotonin-transporter in SMCs (SM22-5HTT+ mice). In these mouse models of PH, Nutlin-3a markedly increased senescent p21-stained PA-SMCs; lung p53, p21, and MDM2 protein levels; and p21, Bax, PUMA, BTG2, and MDM2 mRNA levels; but induced only minor changes in control mice without PH. Marked MDM2 immunostaining was seen in both mouse and human remodeled pulmonary vessels, supporting the use of Nutlins as a PH-targeted therapy. PH prevention or reversal by Nutlin-3a required lung p53 stabilization and increased p21 expression, as indicated by the absence of Nutlin-3a effects in hypoxia-exposed p53 −/− and p21 −/− mice. Conclusions—: Nutlin-3a may hold promise as a prosenescence treatment targeting PA-SMCs in PH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.002434

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. 10.1016/j.jacc.2009.04.018 · DOI · Paper page
  2. 10.1172/JCI200112805 · DOI
  3. 10.1161/01.RES.88.1.e2 · DOI · Paper page
  4. 10.1172/JCI1910 · DOI
  5. 10.1161/circulationaha.105.591321 · DOI · Paper page
  6. 10.1161/01.cir.0000012754.72951.3d · DOI · Paper page
  7. 10.1172/JCI23203 · DOI · Paper page
  8. 10.1172/JCI24838 · DOI · Paper page
  9. 10.1016/S0968-0004(02)02166-7 · DOI · Paper page
  10. 10.1016/S0065-230X(03)01001-7 · DOI
  11. 10.1242/jcs.03293 · DOI · Paper page
  12. 10.1093/cvr/cvr108 · DOI
  13. 10.1002/(SICI)1096-9896(199807)185:3<303::AID-PATH106>3.0.CO;2-P · DOI · Paper page
  14. 10.2353/ajpath.2006.051351 · DOI
  15. 10.1038/32925 · DOI · Paper page
  16. 10.1158/0008-5472.CAN-07-2780 · DOI · Paper page
  17. 10.1158/1541-7786.MCR-09-0144 · DOI
  18. 10.1158/1078-0432.CCR-08-2955 · DOI · Paper page
  19. 10.1164/rccm.201103-0412OC · DOI · Paper page
  20. 10.1161/01.res.0000222546.45372.a0 · DOI · Paper page
  21. 10.1161/circulationaha.110.973750 · DOI
  22. 10.1152/ajplung.00286.2010 · DOI
  23. Lane DP, Brown CJ, Verma C, Cheok CF. New insights into p53 based therapy. Discov Med. 2011;12:107–117.
  24. 10.1038/nature05602 · DOI · Paper page
  25. 10.1152/ajprenal.00230.2007 · DOI · Paper page
  26. Meek DW, Knippschild U. Posttranslational modification of MDM2. Mol Cancer Res. 2003;1:1017–1026.
  27. 10.1164/rccm.201105-0802OC · DOI · Paper page

Cited by

See all 123

Metadata

Authors
Mouraret, N., Marcos, E., Abid, S., Gary-Bobo, G., Saker, M., Houssaini, A., Dubois-Rande, J.-L., Boyer, L., Boczkowski, J., Derumeaux, G., Amsellem, V., & Adnot, S.
Venue
Circulation
Published
2013-04-23
Volume
127
Issue
16
Pages
1664-1676
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2045039711
Cited by
123
References
11
FWCI
7.55
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.